急诊科发放丁丙诺啡-纳洛酮后门诊丁丙诺啡治疗的延续情况
本研究为回顾性描述性分析,纳入2018年3月至2020年3月期间在某城市学术型急诊科接受丁丙诺啡-纳洛酮带回家供应的18岁及以上患者155例。主要结局为索引急诊就诊后3个月填写丁丙诺啡处方的比例,结果为45.2%(70例),6个月时为41.3%(64例)。主要安全终点为6个月内因阿片过量重返急诊的比例,为11%(17例)。作者结论认为急诊发放带回家套装可使近50%患者延续门诊丁丙诺啡治疗,需进一步研究明确急诊发放丁丙诺啡的作用。
要点
- 急诊发放丁丙诺啡-纳洛酮带回家套装后,3个月时45.2%(70/155)患者续填丁丙诺啡处方,6个月时41.3%(64/155)。
- 6个月内因阿片过量重返急诊的患者占11%(17/155),为主要安全终点。
- 研究纳入2018年3月至2020年3月某城市学术型急诊科18岁及以上接受带回家供应的患者155例。
- 作者结论认为急诊发放带回家套装可使近50%患者延续门诊丁丙诺啡治疗,需进一步研究明确其作用。
适用人群与场景
- 年龄18岁及以上、在某城市学术型急诊科接受丁丙诺啡-纳洛酮带回家供应的患者。
研究设计与关键结果
- 研究类型为回顾性描述性分析,纳入2018年3月至2020年3月某城市学术型急诊科接受丁丙诺啡-纳洛酮带回家供应的18岁及以上患者,共审查242份病历,最终分析155例。
- 主要结局:索引急诊就诊后3个月填写丁丙诺啡处方的患者为70例(45.2%)。
- 6个月时填写丁丙诺啡处方的患者为64例(41.3%)。
- 主要安全终点:6个月内因阿片过量重返急诊的患者为17例(11%)。
证据类型、等级与局限
- 证据类型:回顾性描述性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,急诊发放丁丙诺啡带回家套装可使近50%患者延续门诊丁丙诺啡治疗;进一步研究需要明确急诊发放丁丙诺啡的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with opioid use disorder (OUD) are frequently seen in the ED for opioid-related reasons, which creates an opportunity for ED providers to discuss medications for OUD with their patients. Buprenorphine is a partial mu-opioid agonist that is FDA approved to treat OUD and may be initiated in the ED. Traditionally, buprenorphine therapy was initiated under healthcare provider observation; however, other strategies such as at-home induction have also emerged.
METHODS: This was a retrospective descriptive analysis of patients aged 18 years or older who received a take-home supply of buprenorphine-naloxone from an urban, academic ED between March 2018 and March 2020. The primary outcome was the proportion of patients who filled a prescription for buprenorphine at three months after index ED visit. The proportion of patients that filled a prescription for buprenorphine at six months was also evaluated. The primary safety endpoint was the proportion of patients with return ED visit within six months related to opioid overdose.
RESULTS: There were 242 patient records reviewed with 155 patients included in final analysis. Seventy (45.2%) patients filled buprenorphine prescriptions at three months, with 64 (41.3%) who filled buprenorphine prescriptions at six months. Seventeen (11%) patients had a return ED visit related to opioid overdose within six months.
CONCLUSION: Dispensing buprenorphine take-home kits from the ED resulted in continuation of outpatient buprenorphine in almost 50% of patients. Further studies are warranted to define the role of ED-dispensed buprenorphine.
参考来源
- Krenz JR, Hayes BD, Wakeman SE, et al. Continuation of outpatient buprenorphine therapy after dispensing Buprenorphine-Naloxone from the emergency department. Clin Toxicol (Phila). 2021. PMID: 34409916. doi:10.1080/15563650.2021.1968421
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。